Recombinant Human ANO6 Protein，His

ANO6, also known as TMEM16F, is a member of the anoctamin family of proteins that has garnered significant attention in recent years due to its involvement in various physiological processes, particularly in calcium-activated chloride channel activity. Initially discovered in the context of its role in epithelial ion transport, ANO6 has since been implicated in diverse cellular functions including apoptosis, membrane dynamics, and cell migration. Its importance is further highlighted by its association with several diseases, such as cystic fibrosis and certain types of cancer, where dysregulation of chloride channels can lead to severe pathophysiological consequences. The potential for ANO6 as a therapeutic target is underscored by its unique regulatory mechanisms and tissue distribution, making it a candidate for drug development aimed at modulating ion transport in disease states. The study of recombinant ANO6 proteins has facilitated the exploration of its structural and functional properties, allowing for the identification of specific inhibitors and modulators that may have therapeutic implications. As research continues to unveil the complexities of ANO6's role in health and disease, understanding its molecular mechanisms opens new avenues for innovative treatments in conditions where chloride ion transport is disrupted.